ERBB2 and breast cancer: Stained with BODIPY 493/503, the findings demonstrate an elevation of fatty acid content in HER2-positive breast cancer cells following PPARG overexpression (Figure 5E, F), whereas a decrease in fatty acid content is observed upon PPARG gene knockout (Supplementary figure 3E, F).